Plump Andrew Stewart: insider trades.
Plump Andrew Stewart reported 4 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 0 open-market purchases and 3 sales ($5.3M), across 1 company.
- Transactions
- 4
- Purchases (P)
- 0
- Sales (S)
- 3
- Companies
- 1
- Name as filed
- Plump Andrew Stewart
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Takeda Pharmaceutical Co Ltd (TAK) | Director, Officer · President, R&D | 4 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-02 | Takeda Pharmaceutical Co Ltd | S | 116,191 | $18.49 | 145,465 | Form 4 |
| 2026-08-19 | Takeda Pharmaceutical Co Ltd | S | 19,651 | $18.49 | 261,656 | Form 4 |
| 2026-08-10 | Takeda Pharmaceutical Co Ltd | S | 165,393 | $17.1 | 766,569 | Form 4 |
| 2026-07-01 | Takeda Pharmaceutical Co Ltd | A | 125,390 | $0 | 931,962 | Form 4 |
Questions
What stock did Plump Andrew Stewart buy or sell?
Plump Andrew Stewart reported 4 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 0 open-market purchases and 3 sales ($5.3M), across 1 company.
Is Plump Andrew Stewart the same person as other filers with this name?
This page covers SEC CIK 1977689 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/plump-andrew-stewart-1977689.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.